Home / Brands / InvaGen Pharmaceuticals
InvaGen Pharmaceuticals Recalls
11 recalls on record · April 11, 2018 to January 17, 2024 · Drugs
Recalls by year
18
19
20
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
January 17, 2024DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceutica
Hazard: Defective Container: powder may leak out of the pouch
May 27, 2020DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville
Hazard: Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.
July 10, 2019DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total
Hazard: Defective Container; actuator may improperly function and affect dose delivery.
April 24, 2019DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose,
Hazard: Presence of Particulate Matter.
April 24, 2019DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, 200 mg/mL, For IM use only, 1 mL Vial, Single Dose, Rx Only, Manufactured by: Cip
Hazard: Presence of Particulate Matter.
April 24, 2019DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, 2000 mg/10 mL (200 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose,
Hazard: Presence of Particulate Matter.
October 17, 2018DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manuf
Hazard: Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
September 26, 2018DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for: Cip
Hazard: Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date of manufacture in the 90 count bottle size.
April 18, 2018DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla
Hazard: Failed impurities/degradation specifications: Failure to water content and impurity
April 11, 2018DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC 69097-
Hazard: Failed Dissolution Specifications; during stability testing
April 11, 2018DrugsFDA
InvaGen Pharmaceuticals, Inc. recalls buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc.
Hazard: Failed Dissolution Specifications; during stability testing